医学
氨甲环酸
复苏
血液制品
指南
血小板
低温沉淀
因子VIIa
急诊医学
重症监护医学
麻醉
外科
内科学
失血
病理
组织因子
凝结
作者
Jeremy W. Cannon,Mansoor Khan,Ali S. Raja,Mitchell J. Cohen,John J. Como,Bryan A. Cotton,Joseph J. DuBose,Erin E. Fox,Kenji Inaba,Carlos J. Rodríguez,John B. Holcomb,Juan Duchesne
标识
DOI:10.1097/ta.0000000000001333
摘要
DCR can significantly improve outcomes in severely injured bleeding patients. After a review of the best available evidence, we recommend the use of a MT/DCR protocol in hospitals that manage such patients and recommend that the protocol target a high ratio of PLAS and PLT to RBC. This is best achieved by transfusing equal amounts of RBC, PLAS, and PLT during the early, empiric phase of resuscitation. We cannot recommend for or against the use of rVIIa based on the available evidence. Finally, we conditionally recommend the in-hospital use of TXA early in the management of severely injured bleeding patients.
科研通智能强力驱动
Strongly Powered by AbleSci AI